 - Regimen 2 lymphoproliferative malignancies: Patients receive fludarabine phosphate IV over 30 minutes and cyclophosphamide IV over 1 hour on days -5 to -3. Patients with CD20 malignancies also receive rituximab IV over 4-6 hours on days -13, -6, 1, and 8. 